Direct/Indirect costs and QoL in Greek patients with COPD and Bronchial Asthma
V. Zarogoulidou (Thessaloniki, Greece), M. Arvanitidou-Vagiona (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece), D. Ioannidou (Thessaloniki, Greece), M. Mavroudi (Thessaloniki, Greece), P. Zarogoulidis (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece), M. Siarkos (Thessaloniki, Greece), K. Zarogoulidis (Thessaloniki, Greece)
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Zarogoulidou (Thessaloniki, Greece), M. Arvanitidou-Vagiona (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece), D. Ioannidou (Thessaloniki, Greece), M. Mavroudi (Thessaloniki, Greece), P. Zarogoulidis (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece), M. Siarkos (Thessaloniki, Greece), K. Zarogoulidis (Thessaloniki, Greece). Direct/Indirect costs and QoL in Greek patients with COPD and Bronchial Asthma. 3159
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: